Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Clinical
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Clinical
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Therapy areas
Dermatology
Dermatology
Cardio-metabolism
Dermatology
Gastroenterology
Genitourinary
Haematology
Immuno-inflammation
Immuno-oncology
Infectious diseases
Musculoskeletal
Neurology
Nutritional Supplements
Ophthalmology
Orphan-paediatric
Others
Psychiatry
Respiratory
Vaccine
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Dermatology
Vanda Reports results from the EPIONE study of Tradipitant in the treatment of Pruritus in Atopic Dermatitis
Biospace News
-
February 25, 2020
Dermatology
Incyte’s ruxolitinib cream achieves main goal in second late-stage atopic dermatitis study
Firstwordpharma News
-
February 19, 2020
Dermatology
Incyte’s ruxolitinib cream achieves main goal in second late-stage atopic dermatitis...
Firstwordpharma News
-
February 19, 2020
0
Dermatology
Incyte’s Big Dermatitis Week: Ruxolitinib and Baricitinib Hit Primary Endpoints
Biospace News
-
January 28, 2020
0
Dermatology
Incyte’s cream formulation of ruxolitinib hits main goal of late-stage atopic...
Firstwordpharma News
-
January 28, 2020
0
Dermatology
Concert Pharmaceuticals Successfully Completes Open Label Trial of CTP-543 in Patients...
Firstwordpharma News
-
December 19, 2019
0
Dermatology
LEO Pharma’s experimental drug tralokinumab hits main goals of three pivotal...
Firstwordpharma News
-
December 11, 2019
0
1
2
3
...
5
Page 1 of 5
- Advertisement -
LATEST NEWS
Servier and UCL collaborate in fight against immune-inflammatory diseases
Firstwordpharma News
-
December 10, 2019
0
ASH19: Regeneron details first clinical data for bispecific antibody REGN5458 in multiple myeloma
December 9, 2019
Moderna Ships mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study
February 25, 2020
MUST READ
Thermo Fisher & J&J Team Up to Develop Lung Cancer Companion Diagnostic
Biospace News
-
March 12, 2020
0
Zogenix Prices Public Offering of Common Stock – March 03, 2020
Biospace News
-
March 4, 2020
0
Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing
Biospace News
-
February 13, 2019
0
Load more
